Top Markets
#1 Black Phoenix Black Phoenix +21,404.60%
#2 Nesa Nesa +696.88%
#3 Kinesis Silver Kinesis Silver +55.34%
#4 Ontology Gas Ontology Gas +28.45%
#5 BNB Attestation Service BNB Attestation Service +23.44%
#6 QuantixAI QuantixAI +23.07%
#7 EXOD EXOD +22.78%
#8 Biconomy Biconomy +19.06%
#9 Magma Finance Magma Finance +18.07%
#10 Derive Derive +16.29%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Veradermics, Incorporated Veradermics, Incorporated

Veradermics, Incorporated

MANE
Rank in Stocks #4044
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused... Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Veradermics caters to healthcare practitioners and clinicians specializing in dermatologic and aesthetic care for patients of all ages, in addition to the wider medical and scientific community engaged in dermatology. Founded in 2019, the company is based in New Haven, Connecticut.
Share Price
$102.37
Last synced: 2026-08-25
Market Cap
$4.28B
Change (1 day)
3.53%
Change (1 year)
-
Country
US
Trade Veradermics, Incorporated (MANE)

Category

Healthcare
Operating Margin for Veradermics, Incorporated (MANE)
Operating Margin as of 2026 TTM: 0.00%
According to Veradermics, Incorporated latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Veradermics, Incorporated from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.